We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
-14.02%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.88B
AUM Growth
-$1.57B
Cap. Flow
+$103M
Cap. Flow %
1.15%
Top 10 Hldgs %
15.32%
Holding
763
New
20
Increased
297
Reduced
294
Closed
39

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$28M
2
PRGO icon
Perrigo
PRGO
+$25.4M
3
J icon
Jacobs Solutions
J
+$23.4M
4
ICUI icon
ICU Medical
ICUI
+$21.3M
5
SSB icon
SouthState Bank Corp
SSB
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 19.41%
2 Healthcare 18.06%
3 Industrials 15.07%
4 Financials 12.92%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWW icon
201
W.W. Grainger
GWW
$64.3B
$10.1M 0.11%
22,335
-1,517
-6% -$737K
MMS icon
202
Maximus
MMS
$3.32B
$10.1M 0.11%
161,084
+48,050
+43% +$3.25M
BERY
203
DELISTED
Berry Global Group, Inc.
BERY
$9.94M 0.11%
198,100
-43,441
-18% -$2.25M
HUN icon
204
Huntsman Corp
HUN
$2.1B
$9.84M 0.11%
347,283
-21,589
-6% -$729K
UAA icon
205
Under Armour
UAA
$3.01B
$9.79M 0.11%
1,174,628
-119,074
-9% -$1.46M
TPTX
206
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$9.78M 0.11%
130,011
+38,680
+42% +$1.72M
CNMD icon
207
CONMED
CNMD
$1.3B
$9.64M 0.11%
100,672
+29,910
+42% +$3.59M
ITT icon
208
ITT
ITT
$17.1B
$9.57M 0.11%
142,343
-14,212
-9% -$1.01M
MORN icon
209
Morningstar
MORN
$7.57B
$9.45M 0.11%
39,093
-1,098
-3% -$277K
ZWS icon
210
Zurn Elkay Water Solutions
ZWS
$8.6B
$9.4M 0.11%
345,224
-6,207
-2% -$188K
ONTO icon
211
Onto Innovation
ONTO
$10.9B
$9.38M 0.11%
134,546
+39,827
+42% +$2.95M
INSP icon
212
Inspire Medical Systems
INSP
$1.47B
$9.33M 0.11%
51,089
+15,239
+43% +$3.04M
RBA icon
213
RB Global
RBA
$21.5B
$9.31M 0.1%
143,031
+41,722
+41% +$2.45M
WMT icon
214
Walmart Inc
WMT
$909B
$9.28M 0.1%
229,191
-12,789
-5% -$590K
WK icon
215
Workiva
WK
$3.45B
$9.26M 0.1%
140,245
+57,925
+70% +$4.82M
SMPL icon
216
Simply Good Foods
SMPL
$906M
$9.24M 0.1%
244,600
+72,775
+42% +$2.88M
ANGO icon
217
AngioDynamics
ANGO
$605M
$9.19M 0.1%
474,846
+6,506
+1% +$133K
SPY icon
218
State Street SPDR S&P 500 ETF Trust
SPY
$772B
$9.17M 0.1%
24,297
+308
+1% +$126K
CALY
219
Callaway Golf Company
CALY
$3.28B
$9.07M 0.1%
444,410
+132,049
+42% +$2.84M
AYX
220
DELISTED
Alteryx Inc
AYX
$9M 0.1%
185,808
+10,426
+6% +$624K
DBRG icon
221
DigitalBridge
DBRG
$2.92B
$8.93M 0.1%
+457,539
New +$11.2M
ESRT icon
222
Empire State Realty Trust
ESRT
$1B
$8.87M 0.1%
1,262,745
+17,369
+1% +$141K
PLMR icon
223
Palomar
PLMR
$3.79B
$8.85M 0.1%
137,350
+40,881
+42% +$2.47M
GLOB icon
224
Globant
GLOB
$1.65B
$8.72M 0.1%
+50,142
New +$10.2M
APH icon
225
Amphenol
APH
$185B
$8.59M 0.1%
266,872
-10,438
-4% -$363K

Similar funds

Segall Bryant & Hamill's Q2 2022 Portfolio in Review

As of Q2 2022, Segall Bryant & Hamill held 763 positions worth $8.88B, down 15% from $10.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q2 2022 filing shows 20 new, 297 increased, 294 reduced and 39 closed positions. Its largest new stake was Perrigo: 684,450 shares worth $27.7M. The largest sale was Western Alliance Bancorporation, an estimated $35M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Segall Bryant & Hamill's largest Q2 2022 buy was Perrigo: 684,450 shares worth $27.7M.
  • Segall Bryant & Hamill added most to Unilever in Q2 2022, an estimated $28M increase.
  • Segall Bryant & Hamill's biggest Q2 2022 reduction was Western Alliance Bancorporation, cutting an estimated $35M.
  • Segall Bryant & Hamill fully exited Anaplan, Inc. in Q2 2022, selling an estimated $22.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $8.88B portfolio in Q2 2022.
  • Segall Bryant & Hamill opened 20 new positions and closed 39 in Q2 2022.
  • Segall Bryant & Hamill's portfolio value fell 15% quarter-over-quarter to $8.88B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2022, filed 15 Aug 2022.